These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
147 related articles for article (PubMed ID: 12423815)
21. [Fetal ultrasonography and Doppler in isolated congenital heart block]. Monsarrat N; Houfflin-Debarge V; Richard A; Launay D; Lambert M; Hatron PY; Subtil D; Deruelle P Gynecol Obstet Fertil; 2009; 37(7-8):633-44. PubMed ID: 19586792 [TBL] [Abstract][Full Text] [Related]
22. Low titer, isolated anti Ro/SSA 60 kd antibodies is correlated with positive pregnancy outcomes in women at risk of congenital heart block. Tonello M; Hoxha A; Mattia E; Zambon A; Visentin S; Cerutti A; Ghirardello A; Milanesi O; Ruffatti A Clin Rheumatol; 2017 May; 36(5):1155-1160. PubMed ID: 28204891 [TBL] [Abstract][Full Text] [Related]
23. [Intrauterine therapy and outcome in four pregnancies of one mother with anti ro-autoantibody positive Sjoegren's syndrome]. Zemlin M; Bauer K; Dörner T; Altinöz H; Versmold H Z Geburtshilfe Neonatol; 2002; 206(1):22-5. PubMed ID: 11887252 [TBL] [Abstract][Full Text] [Related]
25. Role of fetal echocardiography in the management of isolated fetal heart block with ventricular rate <55 bpm. Singh GK; Shumway JB; Amon E; Marino CJ; Nouri S; Winn HN Am J Perinatol; 1998; 15(12):661-8. PubMed ID: 10333392 [TBL] [Abstract][Full Text] [Related]
26. Ventricular tachycardia secondary to prolongation of the QT interval in a fetus with autoimmune mediated congenital complete heart block. Duke C; Stuart G; Simpson JM Cardiol Young; 2005 Jun; 15(3):319-21. PubMed ID: 15865840 [TBL] [Abstract][Full Text] [Related]
33. [The clinical feature and the fetal therapy of congenital complete A-V block (CCAVB) associated with maternal anti-SSA (B) antibody]. Akita T; Yamada H; Sato H; Makinoda S; Fujimoto S Nihon Sanka Fujinka Gakkai Zasshi; 1994 Dec; 46(12):1371-4. PubMed ID: 7852778 [No Abstract] [Full Text] [Related]
34. In utero treatment of fetal complete heart block with terbutaline. A case report. Chan AY; Silverman RK; Smith FC; Geifman-Holtzman O J Reprod Med; 1999 Apr; 44(4):385-7. PubMed ID: 10319313 [TBL] [Abstract][Full Text] [Related]
35. Anti-Ro/SSA-p200 antibodies in the prediction of congenital heart block. An Italian multicentre cross-sectional study on behalf of the 'Forum Interdisciplinare per la Ricerca nelle Malattie Autoimmuni (FIRMA) Group'. Scarsi M; Radice A; Pregnolato F; Ramoni V; Grava C; Bianchi L; Gerosa M; Mosca M; Ghirardello A; Tani C; Motta M; Quinzanini M; Tincani A; Ruffatti A; Migliorini P; Doria A; Meroni PL; Brucato A Clin Exp Rheumatol; 2014; 32(6):848-54. PubMed ID: 25327946 [TBL] [Abstract][Full Text] [Related]
36. Congenital complete heart block: fetal management protocol, review of the literature, and report of the smallest successful pacemaker implantation. Donofrio MT; Gullquist SD; Mehta ID; Moskowitz WB J Perinatol; 2004 Feb; 24(2):112-7. PubMed ID: 14762451 [TBL] [Abstract][Full Text] [Related]
37. Anti-Ro52 antibody level is an important marker of fetal congenital heart block risk in anti-Ro/SSA antibody positive pregnancy. Miyasato-Isoda M; Waguri M; Yamada Y; Miyano A; Wada Y Mod Rheumatol; 2018 Jul; 28(4):690-696. PubMed ID: 28880700 [TBL] [Abstract][Full Text] [Related]
38. Postnatal outcome of fetal bradycardia without significant cardiac abnormalities. Lin MT; Hsieh FJ; Shyu MK; Lee CN; Wang JK; Wu MH Am Heart J; 2004 Mar; 147(3):540-4. PubMed ID: 14999207 [TBL] [Abstract][Full Text] [Related]
39. Successful outcome of pregnancy after treatment of maternal anti-Ro (SSA) antibodies with immunosuppressive therapy and plasmapheresis. van der Leij JN; Visser GH; Bink-Boelkens MT; Meilof JF; Kallenberg CG Prenat Diagn; 1994 Oct; 14(10):1003-7. PubMed ID: 7899264 [TBL] [Abstract][Full Text] [Related]